by Eric Christianson | Jun 8, 2022 | Medication and Disease State Clinical Pearls For Pharmacists, Psychiatry and Addiction Medication and Disease State Clinical Pearls
Long-Acting Injectable (LAI) Antipsychotics Antipsychotic agents are often discontinued without provider consultation, leading to poorer outcomes and quality of life. Luckily, newer formulations are continually being developed to help address barriers to care and...
by Eric Christianson | Feb 3, 2021 | Medication and Disease State Clinical Pearls For Pharmacists, Psychiatry and Addiction Medication and Disease State Clinical Pearls
Here’s a case scenario where the clinical outcome may have hinged on taking ziprasidone with or without food. KD is a 33-year-old male who was diagnosed with schizophrenia. Olanzapine and risperidone were the first antipsychotics that were tried to help...